EUR 0.06
(-5.84%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2022 | -5.96 Million EUR | 22.23% |
2021 | -7.66 Million EUR | -14.97% |
2020 | -6.66 Million EUR | 10.58% |
2019 | -7.45 Million EUR | -121132.32% |
2018 | -6151.00 EUR | -13.19% |
2017 | -5434.00 EUR | 13.55% |
2016 | -6286.00 EUR | 12.92% |
2015 | -7219.00 EUR | -29.7% |
2014 | -5566.00 EUR | 99.82% |
2013 | -3.09 Million EUR | 9.91% |
2012 | -3.43 Million EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 Q2 | 2.9 Million EUR | 0.0% |
2022 Q4 | -2.69 Million EUR | 0.0% |
2022 Q2 | -3.47 Million EUR | 0.0% |
2022 FY | -6.16 Million EUR | 19.57% |
2021 Q4 | -3.65 Million EUR | 0.0% |
2021 Q2 | -4 Million EUR | 0.0% |
2021 FY | -7.66 Million EUR | -14.97% |
2020 Q2 | -3.19 Million EUR | 0.0% |
2020 FY | -6.66 Million EUR | 10.58% |
2020 Q4 | -3.49 Million EUR | 0.0% |
2019 Q4 | -3.43 Million EUR | 0.0% |
2019 FY | -7.45 Million EUR | -121132.32% |
2019 Q2 | -4.01 Million EUR | 0.0% |
2018 Q2 | -2908.00 EUR | 0.0% |
2018 FY | -6151.00 EUR | -13.19% |
2018 Q4 | -3243.00 EUR | 0.0% |
2017 Q4 | -2904.00 EUR | 0.0% |
2017 FY | -5434.00 EUR | 13.55% |
2017 Q2 | -2530.00 EUR | 0.0% |
2016 Q4 | -2875.00 EUR | 0.0% |
2016 FY | -6286.00 EUR | 12.92% |
2016 Q2 | -3411.00 EUR | 0.0% |
2015 FY | -7219.00 EUR | -29.7% |
2015 Q2 | -3019.00 EUR | 0.0% |
2015 Q4 | -4200.00 EUR | 0.0% |
2014 FY | -5566.00 EUR | 99.82% |
2014 Q4 | -3153.00 EUR | 0.0% |
2014 Q2 | -2413.00 EUR | 0.0% |
2013 Q4 | -1393.00 EUR | 99.83% |
2013 FY | -3.09 Million EUR | 9.91% |
2013 Q3 | -804.5 Thousand EUR | -47223.53% |
2013 Q2 | -1700.00 EUR | 99.79% |
2013 Q1 | -804.5 Thousand EUR | 0.0% |
2012 FY | -3.43 Million EUR | 0.0% |
2012 Q1 | -805 Thousand EUR | 0.0% |
2012 Q2 | -805 Thousand EUR | 0.0% |
2012 Q3 | -805 Thousand EUR | 0.0% |
2012 Q4 | -804.5 Thousand EUR | 0.06% |
2011 Q4 | -805 Thousand EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Crossject Société Anonyme | -11.8 Million EUR | 49.475% |
Spineway SA | -9.03 Million EUR | 34.005% |
Amplitude Surgical SA | 13.24 Million EUR | 145.027% |
Sartorius Stedim Biotech S.A. | 484.5 Million EUR | 101.231% |
EssilorLuxottica Société anonyme | 3.17 Billion EUR | 100.188% |
bonyf N.V. | -39.89 Thousand EUR | -14844.569% |